查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1416342

基因转殖技术市场报告：2030 年趋势、预测与竞争分析

Gene Delivery Technologies Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

基因转移技术的趋势和预测

预计到 2030 年，全球基因转殖技术市场将达到 77 亿美元，2024 年至 2030 年复合年增长率为 14.6%。该市场的主要驱动力是慢性病盛行率的增加、对标靶治疗的需求不断增长以及遗传和细胞研究以及治疗方法交付的进步。全球基因转殖技术市场的未来前景广阔，基因治疗、细胞治疗、疫苗和研究市场充满机会。

深入了解基因转殖技术市场

Lucintel 预测，在 Kymriah 和 Yescarta 取得巨大成功后，由于基于病毒载体的研究和开发项目的增加，生物製品将在整个预测期内仍然是最大的细分市场。

在这个市场中，由于基因疗法的采用越来越多以及临床研究工作的数量不断增加，基因疗法将继续成为最大的细分市场。

由于临床试验数量不断增加、患者基因治疗支出增加以及该地区领先公司的存在，北美在整个预测期内可能仍然是最大的地区。

常问问题

Q1.市场规模为：

A1. 到 2030 年，全球基因转殖技术市场预计将达到 77 亿美元。

Q2.市场成长预测是多少：

A2. 2024年至2030年，全球基因转殖技术市场预计将以14.6%的复合年增长率成长。

Q3.影响市场成长的主要驱动因素是：

A3. 该市场的主要驱动力是慢性病盛行率的增加、对标靶治疗的需求不断增长以及遗传和细胞研究以及治疗方法交付的进步。

Q4.市场的主要细分市场是：

A4. 基因转殖技术市场前景广阔，在基因治疗、细胞治疗、疫苗和研究市场都有机会。

Q5.市场的主要企业是：

A5. 一些主要的基因转殖技术公司是：

  • Thermo Fisher Scientific
  • QIAGEN
  • Horizon Discovery
  • OriGene Technologies
  • Oxford Biomedica
  • SignaGen Laboratories
  • Vectalys

Q6.未来最大的细分市场是什么？

A6.Lucintel 预测，在 Kymriah 和 Yescarta 取得巨大成功之后，由于基于病毒载体的研发计划的增加，生物製品将在整个预测期内保持其最大的细分市场。

Q7. 未来五年预计哪些地区的市场成长最大？

A7. 由于临床试验数量不断增加、患者基因治疗支出增加以及该地区领先公司的存在，预计北美仍将在整个预测期内保持最大的地区地位。

Q8. 可以客製化报告吗？

A8. 是的，Lucintel 提供 10% 的客製化服务，无需额外付费。

目录

第一章执行摘要

第二章 全球基因转殖技术市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球基因转殖技术市场趋势（2018-2023）与预测（2024-2030）
  • 按模式分類的全球基因转移技术市场
    • 生物
    • 科学的
    • 身体的
  • 按方法分類的全球基因转移技术市场
    • 体外
    • 体内
    • 试管内
  • 按应用分類的全球基因转殖技术市场
    • 基因治疗
    • 细胞疗法
    • 疫苗
    • 调查

第四章 2018-2030年区域市场趋势及预测分析

  • 按地区分類的全球基因转殖技术市场
  • 北美基因转殖技术市场
  • 欧洲基因转殖技术市场
  • 亚太地区基因转殖技术市场
  • 其他地区基因转殖技术市场

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 全球基因转殖技术市场成长机会（按模式）
    • 全球基因转殖技术市场成长机会（依方法）
    • 全球基因转殖技术市场成长机会（按应用）
    • 全球基因转殖技术市场成长机会（按地区）
  • 全球基因转殖技术市场新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球基因转殖技术市场的容量
    • 全球基因转殖技术市场的合併、收购与合资
    • 认证和许可

第七章主要企业概况

  • Thermo Fisher Scientific
  • QIAGEN
  • Horizon Discovery
  • OriGene Technologies
  • Oxford Biomedica
  • SignaGen Laboratories
  • Vectalys
简介目录

Gene Delivery Technologies Trends and Forecast

The future of the global gene delivery technologies market looks promising with opportunities in the gene therapy, cell therapy, vaccines, and research markets. The global gene delivery technologies market is expected to reach an estimated $7.7 billion by 2030 with a CAGR of 14.6% from 2024 to 2030. The major drivers for this market are increasing prevalence of chronic diseases, growing demand for targeted therapeutics, and advancements in gene and cell research and therapeutic delivery.

A more than 150-page report is developed to help in your business decisions.

Gene Delivery Technologies by Segment

The study includes a forecast for the global gene delivery technologies by mode, method, application, and region.

Gene Delivery Technologies Market by Mode [Shipment Analysis by Value from 2018 to 2030]:

  • Biological
  • Chemical
  • Physical

Gene Delivery Technologies Market by Method [Shipment Analysis by Value from 2018 to 2030]:

  • Ex Vivo
  • In Vivo
  • In Vitro

Gene Delivery Technologies Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Gene Therapy
  • Cell Therapy
  • Vaccines
  • Research

Gene Delivery Technologies Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Gene Delivery Technologies Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies gene delivery technologies companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the gene delivery technologies companies profiled in this report include-

  • Thermo Fisher Scientific
  • QIAGEN
  • Horizon Discovery
  • OriGene Technologies
  • Oxford Biomedica
  • SignaGen Laboratories
  • Vectalys

Gene Delivery Technologies Market Insights

Lucintel forecasts that biological will remain the largest segment over the forecast period due to growing number of viral vectors-based R&D programs along high success of Kymriah and Yescarta.

Within this market, gene therapy will remain the largest segment due to increasing adoption of gene-based therapies and growing number of clinical research initiatives.

North America will remain the largest region over the forecast period due to risng number of clinical trials, increasing expenditure of patients on gene therapies, and presence of major players in the region.

Features of the Global Gene Delivery Technologies Market

Market Size Estimates: Gene delivery technologies market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Gene delivery technologies market size by mode, method, application, and region in terms of value ($B).

Regional Analysis: Gene delivery technologies market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different modes, methods, applications, and regions for the gene delivery technologies market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the gene delivery technologies market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the gene delivery technologies market size?

Answer: The global gene delivery technologies market is expected to reach an estimated $7.7 billion by 2030.

Q2. What is the growth forecast for gene delivery technologies market?

Answer: The global gene delivery technologies market is expected to grow with a CAGR of 14.6% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the gene delivery technologies market?

Answer: The major drivers for this market are increasing prevalence of chronic diseases, growing demand for targeted therapeutics, and advancements in gene and cell research and therapeutic delivery.

Q4. What are the major segments for gene delivery technologies market?

Answer: The future of the gene delivery technologies market looks promising with opportunities in the gene therapy, cell therapy, vaccines, and research markets.

Q5. Who are the key gene delivery technologies market companies?

Answer: Some of the key gene delivery technologies companies are as follows:

  • Thermo Fisher Scientific
  • QIAGEN
  • Horizon Discovery
  • OriGene Technologies
  • Oxford Biomedica
  • SignaGen Laboratories
  • Vectalys

Q6. Which gene delivery technologies market segment will be the largest in future?

Answer: Lucintel forecasts that biological will remain the largest segment over the forecast period due to growing number of viral vectors-based R&D programs along high success of Kymriah and Yescarta.

Q7. In gene delivery technologies market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to risng number of clinical trials, increasing expenditure of patients on gene therapies, and presence of major players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the gene delivery technologies market by mode (biological, chemical, and physical), method (ex vivo, in vivo, and in vitro), application (gene therapy, cell therapy, vaccines, and research), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Gene Delivery Technologies Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Gene Delivery Technologies Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Gene Delivery Technologies Market by Mode
    • 3.3.1: Biological
    • 3.3.2: Chemical
    • 3.3.3: Physical
  • 3.4: Global Gene Delivery Technologies Market by Method
    • 3.4.1: Ex vivo
    • 3.4.2: In vivo
    • 3.4.3: In vitro
  • 3.5: Global Gene Delivery Technologies Market by Application
    • 3.5.1: Gene Therapy
    • 3.5.2: Cell Therapy
    • 3.5.3: Vaccines
    • 3.5.4: Research

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Gene Delivery Technologies Market by Region
  • 4.2: North American Gene Delivery Technologies Market
    • 4.2.2: North American Gene Delivery Technologies Market by Application: Gene Therapy, Cell Therapy, Vaccines, and Research
  • 4.3: European Gene Delivery Technologies Market
    • 4.3.1: European Gene Delivery Technologies Market by Mode: Biological, Chemical, and Physical
    • 4.3.2: European Gene Delivery Technologies Market by Application: Gene Therapy, Cell Therapy, Vaccines, and Research
  • 4.4: APAC Gene Delivery Technologies Market
    • 4.4.1: APAC Gene Delivery Technologies Market by Mode: Biological, Chemical, and Physical
    • 4.4.2: APAC Gene Delivery Technologies Market by Application: Gene Therapy, Cell Therapy, Vaccines, and Research
  • 4.5: ROW Gene Delivery Technologies Market
    • 4.5.1: ROW Gene Delivery Technologies Market by Mode: Biological, Chemical, and Physical
    • 4.5.2: ROW Gene Delivery Technologies Market by Application: Gene Therapy, Cell Therapy, Vaccines, and Research

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Gene Delivery Technologies Market by Mode
    • 6.1.2: Growth Opportunities for the Global Gene Delivery Technologies Market by Method
    • 6.1.3: Growth Opportunities for the Global Gene Delivery Technologies Market by Application
    • 6.1.4: Growth Opportunities for the Global Gene Delivery Technologies Market by Region
  • 6.2: Emerging Trends in the Global Gene Delivery Technologies Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Gene Delivery Technologies Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Gene Delivery Technologies Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: QIAGEN
  • 7.3: Horizon Discovery
  • 7.4: OriGene Technologies
  • 7.5: Oxford Biomedica
  • 7.6: SignaGen Laboratories
  • 7.7: Vectalys